Our approach includes the use of non-genetic information (e.g. behaviors and demographics) in combination with sequenced genetic information such as Single Nucleotide Polymorphisms (SNPs) to determine, based on an individual’s genetics, the specific behaviors that can be modified by the individual to maintain a healthy weight, reduce the probability of developing diseases such as type II diabetes, and in the future, decrease the chances of that individual developing a wide range of diseases through genetically determined behavior modification.
Expanse believes that the current “one size fits all” healthcare system in the US will give way to a personalized health and wellness system in which consumers are empowered by their genetic data and are provided treatment and lifestyle modification plans customized to their genes. We at Expanse are proud to contribute to and form part of the personalized medicine future, which will disrupt healthcare as we know it.
Overview
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Genomic data mining firm hopes to help personalized medicine become commonplace in 3-5 years | Charles Eldering started developing methods for mining big data back in the late ’90s on a project that characterized consumers based on their purchasing and television viewing habits. Now, a decade and a half later, similar technology is f... |
Reviews 0
FAQ about Expanse Bioinformatics, Inc.
When was Expanse Bioinformatics, Inc. founded?
Expanse Bioinformatics, Inc. was founded in 2004.
What has the press written about Expanse Bioinformatics, Inc.?
Parsers VC has collected 2 articles mentioning Expanse Bioinformatics, Inc., among them “Genomic data mining firm hopes to help personalized medicine become commonplace in 3-5 years”.
Is Expanse Bioinformatics, Inc. still active?
Yes, Expanse Bioinformatics, Inc. is active; its latest activity on Parsers VC dates from Mar 18, 2014.